74 related articles for article (PubMed ID: 8225491)
1. Time-Resolved Synchronous Fluorescence for Biomedical Diagnosis.
Zhang X; Fales A; Vo-Dinh T
Sensors (Basel); 2015 Aug; 15(9):21746-59. PubMed ID: 26404289
[TBL] [Abstract][Full Text] [Related]
2. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes.
Shields PG; Bowman ED; Harrington AM; Doan VT; Weston A
Cancer Res; 1993 Aug; 53(15):3486-92. PubMed ID: 8339251
[TBL] [Abstract][Full Text] [Related]
3. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography.
Baird WM; Lau HH; Schmerold I; Coffing SL; Brozich SL; Lee H; Harvey RG
IARC Sci Publ; 1993; (124):217-26. PubMed ID: 8225488
[TBL] [Abstract][Full Text] [Related]
4. 32P-postlabelling methods for cyclic DNA adducts.
Watson WP; Crane AE; Steiner S
IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
[TBL] [Abstract][Full Text] [Related]
5. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
6. Analysis of DNA adducts in smokers' lung and urothelium by 32P-postlabelling: metabolic phenotype dependence and comparisons with other exposure markers.
Bartsch H; Castegnaro M; Camus AM; Schouft A; Geneste O; Rojas M; Alexandrov K
IARC Sci Publ; 1993; (124):331-40. PubMed ID: 8225503
[TBL] [Abstract][Full Text] [Related]
7. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
[TBL] [Abstract][Full Text] [Related]
8. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
9. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
Talaska G; Roh JH; Getek T
J Chromatogr; 1992 Sep; 580(1-2):293-323. PubMed ID: 1400827
[TBL] [Abstract][Full Text] [Related]
10. 32P-postlabelling in studies of polycyclic aromatic hydrocarbon activation.
Ross JA; Nesnow S
IARC Sci Publ; 1993; (124):71-8. PubMed ID: 8225511
[TBL] [Abstract][Full Text] [Related]
11. DNA adduct determination in humans.
Poirier MC; Weston A
Prog Clin Biol Res; 1991; 372():205-18. PubMed ID: 1956919
[TBL] [Abstract][Full Text] [Related]
12. Immunologic methods for the detection of carcinogen adducts in humans.
Santella RM; Yang XY; Hsieh LL; Young TL
Prog Clin Biol Res; 1990; 340C():247-57. PubMed ID: 2199982
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
